About
Company Overview
Management Team
Board of Directors
Advisors
Partnering
Careers
CBD
Programs
Overview
Graft versus Host Disease (GVHD)
Acute and Chronic Pain
Additional Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEDAR Filings
SEC Filings
Stock Information
Corporate Governance
Contact
About
Company Overview
Management Team
Board of Directors
Advisors
Partnering
Careers
CBD
Programs
Overview
Graft versus Host Disease (GVHD)
Acute and Chronic Pain
Additional Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEDAR Filings
SEC Filings
Stock Information
Corporate Governance
Contact
Press Releases
Menu
Overview
Press Releases
Company Information
Stock Information
SEC Filings
Corporate Governance
Recent Press Releases
Kalytera Announces Modification to Sale Period for Shares Issued under Payments Agreement
February 19, 2020
Kalytera Completes Share Issuance under Payments Agreement
February 18, 2020
Kalytera Announces New Payments Agreement with the Salzman Group of Israel
February 7, 2020
Kalytera Announces Notice of Allowance of Additional U.S. Patent for Prevention and Treatment of Graft Versus Host Disease
February 5, 2020
Kalytera Announces Intention to Seek Amendment of Secured Convertible Debentures Due December 2019
December 20, 2019
Kalytera Announces Extension of Maturity Date of Promissory Note
December 16, 2019
Kalytera Reports Third Quarter 2019 Financial Results
December 2, 2019
View all News and Insights
Browse by Year
2020
2019
2018
2017
2016
2015
